Denali Therapeutics Inc.DNLINASDAQ
Loading
Research and development spending
3Y CAGR
+5.3%/yr
vs +25.8%/yr prior
5Y CAGR
+14.5%/yr
Recent deceleration
Acceleration
-20.5pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $418.78M | +5.6% |
| 2024 | $396.44M | -6.5% |
| 2023 | $423.88M | +18.2% |
| 2022 | $358.73M | +35.2% |
| 2021 | $265.35M | +24.8% |
| 2020 | $212.62M | +9.9% |
| 2019 | $193.38M | +35.1% |
| 2018 | $143.18M | +92.3% |
| 2017 | $74.46M | -1.6% |
| 2016 | $75.70M | - |